Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
New Strong Sell Stocks for April 26th
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
Anika Therapeutics (ANIK - Free Report) is a global, integrated orthopedic medicines company. The Zacks Consensus Estimate for its current year earnings has been revised 454.8% downward over the last 60 days.
Alimera Sciences (ALIM - Free Report) is a biopharmaceutical company that specializes in the research, development, and commercialization of prescription ophthalmic pharmaceuticals. The Zacks Consensus Estimate for its current year earnings has been revised 302.1% downward over the last 60 days.
Adaptimmune Therapeutics is a biopharmaceutical company that focuses on cancer immunotherapy products based on T-cell receptor platform. The Zacks Consensus Estimate for its current year earnings has been revised almost 18.7 % downward over the last 60 days.
View the entire Zacks Rank #5 List.